
In 2019, the number of the developed drug products of the enterprise is over 40 drugs of various pharmacotherapeutic groups. The range of industrial production in comparison with the start of production increased by a factor of more than 20 times, in monetary terms - by a factor of more than 30 times. In 2018, with the participation of foreign investments further modernization of production was started.

On August 6, 2018, the grand opening ceremony of the landscape complex was held on the occasion of the start of construction of the YUSUF HAMID PHARMA R&D CENTER on the basis of the state-owned enterprise ACADEMPHARM. Indian pharmaceutical company Cipla Limited, headed by the chairman of the company Yusuf Hwaja Hamid, invested $ 1 million in the construction of this research and technology center.

In 2017, the company concluded the contracts for the supply of a purified water production system with the company LLC “Thermodistillation RV” (ООО «Термодистилляция РВ») (Ukraine), a film coating machine for tablets produced by Nicomac (Italy), a roller compactor produced by the company AlexanderwerkAG (Germany).

In 2015-2016, storage facilities were placed into operation for storage of excipients and active ingredients, packaging materials and finished products in accordance with the GMP requirements. The total storage area of the state-owned enterprise ACADEMPHARM is more than 1250 sq.m.

In 2014, in accordance with the Decree of the President of the Republic of Belarus No. 174 “On Certain Measures for the Development of the Pharmaceutical Industry” in 2013-2014, a new administration and amenity building with a storage facility was placed into operation. The area of new production facilities is more than 400 sq.m.

In 2012, all units of production equipment and production of the forms of presentation such as hard gelatin capsules, tablets, and powders in bags were implemented.

The first release of industrial production was carried out in 2010. Due to the epidemic of influenza virus A (H1N1) by order of the Ministry of Health of the Republic of Belarus, the production of the antiviral drug “Flustop” («Флустоп») in the form of hard gelatin capsules was implemented. The state-owned enterprise ACADEMPHARM is the only manufacturer of this drug product in the Republic of Belarus.